Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from FDA

Why Nymox Pharma Shares Sinking to 52-Week Low?

Nymox Pharmaceutical Corporation (NASDAQ:NYMX) has received a Refusal to File (RTF) letter from FDA regarding its marketing application for Fexapotide Triflutate. Nymox's position is that clarifications remain to be resolved at a follow-up meeting and that some significant inconsistencies were involved. In March, the company submitted a Fexapotide Triflutate application for benign prostatic…

Benzinga

FDA Removes Clinical Hold On Ocugen's COVID Vaccine Trial

The FDA has lifted the clinical hold on Ocugen Inc's (NASDAQ:OCGN) Phase 2/3 trial, OCU-002, for Covaxin (BBV152), a whole virus inactivated COVID-19 vaccine candidate. In April, the agency paused the trials of the shot, Covaxin, after an inspection of a Bharat Biotech facility by the World Health Organization (WHO) revealed deficiencies…

Benzinga

Pfizer/BioNTech say 3 COVID shots elicit good response in children under 5

Drugmakers Pfizer Inc and BioNTech SE said on Monday that three doses of their COVID-19 vaccine generated a strong immune response in children under age 5 and was safe and well-tolerated in their clinical trial.

Reuters

From analysis to the latest developments in health,
read the most diverse news in one place.

Pfizer says 3 COVID shots protect children under 5

Pfizer says three small doses of its COVID-19 vaccine protect kids under 5 and that it plans to give the data to U.S. regulators later this week

The Independent UK

Abbott CEO apologizes for the formula shortage as the first overseas shipment arrives

"We're sorry to every family we've let down," wrote CEO Robert Ford. The shuttered plant at the heart of the shortage will reopen in June, but it may take months before production is back to normal.

WEKU

Jif peanut butter products recalled over salmonella outbreak traced to Kentucky plant

Cases have been reported in 14 states

The Independent UK

Abbott CEO says ‘sorry’ over baby formula shortage and vows to ensure ‘this never happens again’

Chairman and CEO of the embattled company Robert Ford insists the company is taking steps ‘to ensure this never happens again’

The Independent UK

Read news from The Economist, FT, and more,
with one subscription

The U.S. Food and Drug Administration, along with Centers for Disease Control and Prevention, and others have been investigating a multistate outbreak of salmonella senftenberg infections and they are linked to a product so many of us enjoy daily.

McClatchy Washington Bureau

Jif peanut butter is being recalled for potential salmonella contamination

The J.M. Smucker Co. announced the recall on Friday. The Food and Drug Administration says current epidemiologic evidence points to a Lexington, Ky., facility as the likely cause of the outbreak.

WEKU

Formula scarcity spurs deeper questions

Corporate consolidation of baby formula-makers got us to this point of crisis

Salon

Is Trump to blame for the baby formula shortage?

Reexamining a trade deal with bipartisan support

The Independent UK

Amanda Little: US should follow the EU model for baby formula

Startup Bobbie introduced its infant formula product in January 2021, the first new brand to be approved for sale in nearly a decade. It was a small operator representing a tiny fraction of the $4 billion U.S. formula market, but when shortages began roiling the industry in recent months, Bobbie…

Tribune News Service

Editorial: The shame of America’s baby-formula shortage

When the sudden COVID-19 shutdown caused people to hoard toilet paper, the nation was half amused by the inability to find a roll on any retail shelf.

Los Angeles Times

6 Stocks To Watch Amid Monkeypox Outbreak

A Monkeypox outbreak has been reported in several European countries, two cases in Canada and one confirmed case in a man from Massachusetts.

Benzinga

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

FDA Approves Regeneron and Sanofi's Dupixent (dupilumab) For Eosinophilic Esophagitis (EoE) Ahead of Schedule

The U.S. Food and Drug Administration (FDA) has approved Regeneron Pharmaceuticals, Inc.

Benzinga

New FDA 510(k) Clearance Expands Anika's Sports Medicine Soft Tissue Portfolio

Anika Therapeutics Inc (NASDAQ:ANIK) has received FDA 510(k) clearance for the X-Twist Knotless Fixation System, a platform of suture anchors designed to be mechanically robust, easy to use, and support healing for critical repairs such as rotator cuff repair. According to SmartTRAK, nearly 670,000 rotator cuff procedures were performed in 2021, mainly in…

Benzinga

AbbVie Submits FDA Application For Continuous, 24-Hour Infusion Therapy For Parkinson's

AbbVie Inc (NYSE:ABBV) submitted its FDA marketing application for ABBV-951, a solution of levodopa and carbidopa prodrugs being evaluated in advanced Parkinson’s patients who don’t respond well to oral therapy. AbbVie’s theory here revolves around using a continuous, 24-hour infusion of its therapy. The levodopa and carbidopa prodrugs are delivered in small doses…

Benzinga

CHMP Backs Approval of Lilly/Incyte's Olumiant For Patchy Hair Loss

The European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion for Eli Lilly And Co (NYSE:LLY) and Incyte Corporation's (NASDAQ:INCY) Olumiant (baricitinib) for severe alopecia areata (AA). If approved, Olumiant would be the first centrally-authorized oral treatment and first JAK inhibitor for severe AA in the European Union. …

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

Mid-Afternoon Market Update: Dow Dips Over 500 Points; Ross Stores Shares Slide

U.S. stocks extended losses toward the end of trading, with the Dow Jones dropping more than 500 points on Friday.

Benzinga

The Trials And Tribulations Of Psychedelic Research

This article by Natasha Sumner was originally published on Microdose and appears here with permission.

The Independent UK

Is Trump to blame for the baby formula shortage?

Reexamining a trade deal with bipartisan support

Benzinga

Mid-Day Market Update: Dow Tumbles 200 Points; TherapeuticsMD Shares Jump

U.S. stocks traded lower midway through trading, with the Dow Jones dropping around 200 points on Friday.

Benzinga

38 Stocks Moving In Friday's Mid-Day Session

Gainers Leju Holdings Limited (NYSE: LEJU) surged 27.8% to $4.0413.

Benzinga

LPCN: OLE Results

By John Vandermosten, CFA NASDAQ:LPCN READ THE FULL LPCN RESEARCH REPORT

Benzinga

Cannabis Regulatory Update: FDA On CBD Reg Stalling, NY Issues 58 Cannabis Grow Licenses, LA's State Worker Protections

FDA Chief Recognizes Slow Progress On CBD Regulations Dr. Robert M. Califf confirmed on Thursday at a congressional panel that the FDA has made little progress on the regulatory framework around CBD products over the years since Trump signed the Farm Bill in late 2018.

1 … 204 205 206 207

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

World Health Organization

Food and Drug Administration

336 stories

LLY

319 stories

Centers for Disease Control and Prevention

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.